Société Respirerx Pharmaceuticals Inc OTC Bulletin Board
Actions
Recherche biotechnologique et médicale
Cours en clôture
Autres places de cotation
|
||
- USD | - |
Métier
Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Arnold Lippa
CEO | Chief Executive Officer | 77 | 22/03/13 |
Jeff Margolis
DFI | Director of Finance/CFO | 68 | 22/03/13 |
Richard Purcell
CTO | Chief Tech/Sci/R&D Officer | 63 | 15/10/14 |
David Dickason
PRN | Corporate Officer/Principal | - | 15/09/20 |
Marc M. Radin
AUD | Comptroller/Controller/Auditor | - | 01/10/13 |
Administrateurs
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Arnold Lippa
CEO | Chief Executive Officer | 77 | 22/03/13 |
Director/Board Member | - | 22/03/23 | |
Jeff Margolis
DFI | Director of Finance/CFO | 68 | 22/03/13 |
Classe d'actions
Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
---|---|---|---|---|---|
Action A | 1 | 365 418 647 | 341 184 734 ( 93,37 %) | 0 | 93,37 % |
Action B | 0 | 37 500 | 0 | 0 |
Coordonnées société
RespireRx Pharmaceuticals, Inc.
126 Valley Road Suite C
07452, Glen Rock
+201 444 4947
http://www.respirerx.comSecteur
Varia. 1 janv. | Capi. | |
---|---|---|
+17,09% | 124 Md | |
+18,92% | 112 Md | |
+3,52% | 22,94 Md | |
-11,91% | 17,02 Md | |
-16,50% | 16,88 Md | |
-39,57% | 16,87 Md | |
+2,91% | 13,63 Md | |
+22,69% | 11,61 Md | |
+107,97% | 10,31 Md |
- Bourse
- Actions
- Action RSPI
- Action
- Société Respirerx Pharmaceuticals Inc